The Retraction Mother Lode?

Editors at 23 scientific journals demand validation of nearly 200 studies authored by a Japanese anesthesiologist.

Written bySabrina Richards
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, SHARON HALL SHIPP

A single author may be retracting a record 193 studies if they don’t stand up to scrutiny, reports RetractionWatch. A letter, signed by editors-in-chief at 23 journals and posted online at Anesthesia & Analgesia, asks 7 institutions that have employed Yoshitaka Fujii to scrutinize the anesthesiologist's original data, verify its authenticity, and ascertain that Fujii obtained ethical approval for the studies. Additionally, they must confirm that the studies actually occurred. Papers that can’t meet these standards will be retracted, the editors warned.

Fujii, who was fired from Toho University in Tokyo, Japan, after he published several studies without an ethics committee’s approval, may become the record-holder for most retracted papers. Ken Takamatsu, dean of Toho University’s faculty of medicine, told ScienceInsider that Fujii claimed to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies